—
LONDON, July 21LONDON, July 21 /PRNewswire/ -- Professor Terje Pedersen (Ullevål University Hospital, Oslo, Norway), lead investigator for the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study, will provide an update on the study on Monday the 21st July.
Also present in London will be Sir Richard Peto (Professor of Medical Statistics and Epidemiology and Co-director of the Clinical Trials Service Unit, University of Oxford) Professor Rory Collins (BHF Professor of Medicine and Epidemiology at the University of Oxford and Co-director of the Clinical Trials Service Unit) and Professor Ingar Holme, PhD, (Professor of Biostatistics, University of Oslo and Ullevål University Hospital, Oslo, Norway), SEAS steering committee statistician.
The London panel will be joined by Professor Eugene Braunwald (Professor of Medicine at Harvard Medical School) who will participate via Web link from Boston and Professor Robert M Califf (Professor of Medicine, Head of Duke Clinical Research, Duke University) available via phone link.
You are invited to join us at:
The Hilton London Metropole Hotel,
King Suite (3rd Floor, West Wing),
225 Edgware Road, London W2 1JU
When: 21st July at 5.30pm for a 6pm start, BST
OR
The press conference will be Webcast live, and archived, available at:
http://clients.mediaondemand.net/pedersen/live.asx
http://clients.mediaondemand.net/pedersen/archive.asx
Additionally the press conference can be accessed via satellite and full coordinates for USA and Europe will be issued by 1pm BST.
There will be a Q&A session after the press announcement. The Q&A session is only available for members of the media.
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
